PROTON THERAPY USA LIMITED
ActiveCompany number 07964052
London, England · Incorporated 24 February 2012
Flat 1 55 Portland Place, London, W1B 1QL, England
Last updated on 17 September 2026
Manufacture of irradiation, electromedical and electrotherapeutic equipment · SIC 26600
Company overview
PROTON THERAPY USA LIMITED is an active private limited company incorporated on 24 February 2012 under the jurisdiction of England and Wales. The company is registered at Flat 1, 55 Portland Place, London W1B 1QL. Its principal activity is classified under SIC code 26600.
The company remains dormant, with its most recent accounts prepared to 30 June 2025 showing dormant status. The next accounts are due by 31 March 2027. A confirmation statement was filed on 15 April 2026 with no updates, and the next statement is due by 17 April 2027.
Jonathan Jay Sinclair serves as both company secretary and director, residing in the United States. Dr Michael Jeffrey Sinclair, a British-Israeli national resident in Israel, is the other director. The sole person with significant control is Emess Biosciences Limited, which holds 75-100% of the shares and voting rights.
There are no charges, no insolvency history, and the company has never been liquidated.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Officers
No officers on record.
Persons with significant control
Funding
0 funding roundsNo funding rounds on record.
Filing history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly
Companies at this postcode
W1B 1QL